Bifeprunox - Atypical Antipsychotic Drug

 

Key Data:

Drug (brand / generic)
Bifeprunox mesilate
Company / licensee
Solvay Pharmaceuticals / Lundbeck / Wyeth
Therapy class
Antipsychotic
Product description
Partial dopamine D2 agonist
Current indication
Treatment of schizophrenia
Market sector
CNS
Development status
Development ceased



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development